0.6398
0.96%
0.0061
アフターアワーズ:
.64
0.0002
+0.03%
Bionomics Ltd Adr (BNOX) 最新ニュース
Market Watch: Bionomics Ltd. ADR (BNOX)’s Noteworthy Drop, Closing at 0.64 - The Dwinnex
Bionomics Ltd. ADR (BNOX) stock analysis: A simple moving average approach - US Post News
Ratio Analysis: Unpacking Bionomics Ltd. ADR (BNOX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Is it possible to buy Bionomics Ltd. ADR(BNOX) shares at a good price now? - US Post News
Investor’s Toolkit: Key Ratios for Assessing Bionomics Ltd. ADR (BNOX)’s Performance - The Dwinnex
Recursion Pharmaceuticals Inc (RXRX) Has Recovered 32.29% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
An analyst sees good growth prospects for Bionomics Ltd. ADR (BNOX) - SETE News
Bionomics Ltd. ADR [BNOX] Stock trading around $0.83 per share: What’s Next? - The DBT News
Bionomics Ltd. ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Bionomics Ltd. ADR (BNOX) Stock: A Year of Decreases and Increases - The InvestChronicle
Nauticus Robotics Inc [KITT] Stock trading around $0.13 per share: What’s Next? - The DBT News
Chuy’s Holdings Inc [CHUY] fell -2.33% so far this year. What now? - The DBT News
Market cap of Kintara Therapeutics Inc [KTRA] reaches 15.16M – now what? - The DBT News
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Bionomics commences phase 3 trial for social anxiety treatment - Investing.com
Bionomics faces Nasdaq delisting over share price - Investing.com
Stock Market Recap: Bionomics Ltd. ADR (BNOX) Concludes at 0.69, a -2.76 Surge/Decline – DWinneX - The Dwinnex
Results from Bionomics Ltd. ADR (BNOX) show potential – US Post News - US Post News
Bionomics stock retains Buy rating from H.C. Wainwright By Investing.com - Investing.com
Bionomics Ltd. ADR's latest rating changes from various analysts – Knox Daily - Knox Daily
Closing Bell Recap: Bionomics Ltd. ADR (BNOX) Ends at 0.84, Reflecting a -14.97 Downturn – DWinneX - The Dwinnex
BNOX’s Stochastic Averages Dip: Analyzing Bionomics Ltd. ADR’s Stock Performance - The InvestChronicle
Bionomics secures $70 million in private placement By Investing.com - Investing.com
BNOX's price-to-free cash flow ratio: What it means for investors – US Post News - US Post News
Bionomics secures $70 million in private placement - Investing.com
Ratios Reveal: Breaking Down Bionomics Ltd. ADR (BNOX)'s Financial Health – DWinneX - The Dwinnex
There is no doubt that Bionomics Ltd. ADR (BNOX) ticks all the boxes. – Sete News - SETE News
Bears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' Now - Yahoo Movies Canada
Bionomics Ltd. ADR (BNOX) Stock: Navigating a Year of Volatility - The InvestChronicle
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting - GlobeNewswire Inc.
Bears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' Now - Yahoo Singapore News
Bionomics reports promising PTSD treatment trial results By Investing.com - Investing.com
10 Best Australian Stocks To Buy - Yahoo Finance
Bionomics (BNOX) Meets Goals in PTSD Study, Stock Rallies 244% - Nasdaq
Bionomics (BNOX) Up on Positive Updates on PTSD & SAD Candidate - Zacks Investment Research
Rise and Shine: Everything you need to know before the ASX opens - Stockhead
Bionomics (BNOX) Stock Price, News & Analysis - MarketBeat
Check-up: What's happening with the ASX small cap health stocks? - Stockhead
大文字化:
|
ボリューム (24 時間):